查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1848774

子宫操作器械市场（按产品类型、应用、最终用户和分销管道）－全球预测 2025-2032

Uterine Manipulation Devices Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，子宫操纵装置市场规模将成长至 5.4153 亿美元，复合年增长率为 6.95%。

主要市场统计数据
基准年2024年 3.1629亿美元
预计2025年 3.3877亿美元
预测年份：2032年 5.4153亿美元
复合年增长率（%） 6.95%

子宫操作装置的全面介绍强调了临床需求、创新途径、程序整合和相关人员的优先事项

子宫操作器械在微创妇科手术中发挥着至关重要的作用，它能够在子宫切除术和肌瘤切除术等手术中实现子宫暴露、子宫定位和安全切除。器械设计的进步与手术技术的变革密切相关，包括腹腔镜和子宫镜的广泛应用以及机器人辅助平台的整合。因此，临床医生、采购主管和产品开发人员正在重新评估器械规格、灭菌通讯协定和生命週期成本，以确保临床结果与组织优先事项保持一致。

本介绍为推动设备创新的临床需求提供了一个框架：病患安全、手术效率、外科医生人体工学以及与现有手术室生态系统的兼容性。监管预期和感染预防需求推动了一次性选择的重要性，而环境和成本方面的考虑则意味着可重复使用的设计在某些情况下具有重要意义。同时，设备机械结构（例如多关节臂和充气式操纵器）与手术工作流程之间的相互作用决定了手术过程中的实际价值。

最后，引言部分提出了相关人员必须在临床表现、供应链弹性和法规遵循之间取得平衡的期望。读者在评估筹资策略和产品开发优先顺序时，应准备好考虑设备类型、应用和最终用户需求之间的跨职能权利。

技术、法规和工作流程的变革将影响子宫操纵装置的设计、采用、安全通讯协定和手术实践模式

受临床实践、监管重点和技术融合的推动，子宫操作器械市场正在经历一系列变革。机器人辅助手术和增强型腹腔镜平台推动了对更精细控制、可重复定位以及与摄影系统和器械无缝集成的器械的需求，从而推动了产品向更高精度和更符合人体工学的设计方向转变。同时，对感染预防和单一病人安全的日益重视，也加速了一次性操作器械在许多领域的应用。

供应链动态和製造创新也在重塑市场。先进的聚合物、低调的关节机构和气动充气系统正在推动减少组织创伤和提高手术可视度的设计。监管机构更加重视可追溯性、标籤和人为因素数据，鼓励製造商投资可用性测试和上市后监测。同时，医疗保健系统正在平衡环境因素和临床需求，促使人们考虑回收计划和生命週期分析。

这种转变既带来了颠覆，也带来了机会。将产品开发与手术室工作流程、灭菌方法和数位互通性结合的相关人员，将加速产品的应用。涵盖手术机器人、材料科学和分销管道的策略伙伴关係将日益决定哪些解决方案能够获得临床和商业性青睐。

评估 2025 年美国实施的关税对子宫操纵装置供应链的累积营运、采购、定价和合规影响

2025年对医疗设备投入品和成品征收关税，为製造商、经销商和医疗保健采购负责人带来了一系列重要考量。关税带来的成本压力促使企业进行采购审查和供应商多元化，许多公司重新评估依赖进口的零件，并探索近岸外包和扩大国内製造产能，以降低贸易政策波动带来的风险。同时，经销商和医院采购团队也审查了库存策略和合约条款，以在应对短期成本波动的同时保持供应的连续性。

除了采购成本外，关税也影响产品设计和物料清单（BOM）优化方面的决策。製造商优先考虑材料清单标准化和模组化设计，以便在地采购非关键组件，从而降低关税清关风险。同时，进口成品关税的上涨正促使一些公司重新评估其分销布局和通路策略，包括製造商直销、独立分销商和电商平台的相对角色。

最后，关税使监管合规性和关税分类再次成为焦点，因为错误分类和文件不足可能会增加成本影响。相关人员应该预期，供应链透明度、合约弹性和策略性库存缓衝将继续成为2025年后贸易环境中的标准风险缓解策略。

细分主导的洞察揭示了影响设备开发、筹资策略和临床采用的产品、应用、最终用户和分销动态

了解市场需要对产品、应用、最终用户和分销细分有细緻的了解，这有助于产品设计、市场进入策略和临床定位。我们根据产品类型研究了抛弃式和可重复使用机械手市场。我们进一步探讨了机械和气动扩张式抛弃式机械手，以及咬合臂和手动螺丝式可重复使用机械手，重点突出了一次性使用的简易性和耐用机械的复杂性之间不同的工程优先级。我们涵盖了腹腔镜子宫镜、传统和机器人腹腔镜子宫肌瘤切除术以及子宫腔镜和腹腔镜子宫肌瘤切除术，重点介绍了手术细微差别如何决定设备的外形规格和控制机制。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用一次性子宫操纵器来最大限度地减少微创手术期间的交叉污染
  • 将智慧感测器技术整合到子宫操纵器中，以提高手术精度和安全性
  • 单孔腹腔镜手术的扩展推动了对低调手术的需求
  • 在复杂的子宫切除术中，越来越多地使用关节式子宫操纵器来改善操作和可视性
  • 加强医疗设备公司与研究机构的合作，开发下一代子宫操纵器
  • 随着妇科手术数量的增加，具有成本效益的子宫操作解决方案在新兴市场变得越来越重要。

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 子宫操作器械市场（依产品类型）

  • 一次性使用机械手
    • 机器
    • 气压充气
  • 可重复使用的机械手
    • 铰接臂
    • 手动螺丝

9. 子宫操作器械市场（依应用）

  • 子宫切除术
    • 腹腔镜
      • 传统的
      • 机器人协助
  • 子宫肌瘤切除术
    • 子宫镜检查
    • 腹腔镜

第 10 章子宫操作器械市场（依最终用户）

  • 门诊手术中心
    • 自主型
    • 医院相关
  • 诊所
    • 门诊
    • 私人的
  • 医院
    • 社群
    • 第三纪

第 11 章子宫操作器械市场（依分销管道）

  • 直接地
    • 製造商销售负责人
    • 在线的
  • 批发商
    • 医疗设备经销商
    • OEM合作伙伴
  • 电子商务
    • 公司网站
    • 第三方入口网站

第 12 章：子宫操作器械市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章子宫操作器械市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章 子宫操作器械市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Ethicon, Inc.
    • Karl Storz SE & Co. KG
    • Medtronic plc
    • B. Braun Melsungen AG
    • ConMed Corporation
    • CooperSurgical, Inc.
    • Richard Wolf GmbH
    • Stryker Corporation
    • Smith & Nephew plc
    • Teleflex Incorporated
Product Code: MRR-2D64BA93A530

The Uterine Manipulation Devices Market is projected to grow by USD 541.53 million at a CAGR of 6.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 316.29 million
Estimated Year [2025] USD 338.77 million
Forecast Year [2032] USD 541.53 million
CAGR (%) 6.95%

A comprehensive introduction to uterine manipulation devices highlighting clinical imperatives, innovation pathways, procedural integration, and stakeholder priorities

Uterine manipulation devices play a pivotal role across minimally invasive gynecologic surgery by enabling exposure, uterine positioning, and safe resection during procedures such as hysterectomy and myomectomy. Advances in device design have been tightly coupled to shifts in surgical technique, including the wider adoption of laparoscopic and hysteroscopic approaches and the integration of robotic-assisted platforms. As a result, clinicians, procurement leaders, and product developers are re-evaluating device specifications, sterilization protocols, and lifecycle costs to align clinical outcomes with organizational priorities.

This introduction frames the clinical imperatives that drive device innovation: patient safety, procedure efficiency, ergonomics for surgeons, and compatibility with existing operating room ecosystems. Regulatory expectations and infection-prevention imperatives have elevated the prominence of single-use disposable options, even as environmental and cost considerations keep reusable designs relevant in specific contexts. Concurrently, the interplay between device mechanics - such as articulating arms and inflatable manipulators - and surgical workflow determines the practical value delivered during surgeries.

Finally, the introduction sets the expectation that stakeholders must balance clinical performance, supply chain resilience, and regulatory compliance. Readers should be prepared to consider cross-functional trade-offs between device type, application, and end-user requirements as they evaluate procurement strategies and product development priorities.

Transformative technological, regulatory, and workflow shifts reshaping uterine manipulation device design, adoption, safety protocols, and surgical practice patterns

The landscape for uterine manipulation devices is undergoing a series of transformative shifts driven by clinical practice changes, regulatory focus, and technological convergence. Robotic-assisted surgery and enhanced laparoscopic platforms have increased demand for devices that offer finer control, repeatable positioning, and seamless integration with camera systems and instruments, shifting product requirements toward greater precision and ergonomic design. At the same time, heightened attention to infection prevention and single-patient safety has accelerated uptake of disposable manipulators in many settings, even as reusable systems retain advantages where sterilization infrastructure and cost models favor reuse.

Supply chain dynamics and manufacturing innovations are also reshaping the marketplace. Advanced polymers, low-profile articulating mechanisms, and pneumatic inflation systems are enabling designs that reduce tissue trauma and improve surgical visualization. Regulatory agencies are placing more emphasis on traceability, labeling, and human factors data, prompting manufacturers to invest in usability testing and post-market surveillance. Concurrently, health systems are balancing environmental concerns against clinical imperatives, prompting exploration of recycling programs and life-cycle analyses.

Taken together, these shifts create both disruption and opportunity. Stakeholders who align product development with operating-room workflows, sterilization practices, and digital interoperability will be positioned to accelerate adoption. Strategic partnerships across surgical robotics, materials science, and distribution channels will increasingly determine which solutions achieve clinical and commercial traction.

Assessing the cumulative operational, sourcing, pricing, and compliance effects of United States tariffs introduced in 2025 on uterine manipulation device supply chains

The imposition of tariffs on medical device inputs and finished goods in 2025 introduced a material set of considerations for manufacturers, distributors, and healthcare purchasers. Tariff-driven cost pressure has prompted sourcing reviews and supplier diversification, with many firms reassessing import-dependent components and exploring nearshoring or expanded domestic production capacity to mitigate exposure to trade policy volatility. In parallel, distributors and hospital procurement teams have revisited inventory strategies and contractual terms to preserve supply continuity while managing short-term cost fluctuations.

Beyond procurement costs, tariffs have also affected decisions about product design and BOM (bill of materials) optimization. Manufacturers are prioritizing component standardization and modular designs that allow for localized sourcing of non-critical parts, thereby reducing the risk of tariff pass-through. At the same time, increased duties on imported finished devices have led some firms to re-evaluate distribution footprints and channel strategies, including the relative roles of manufacturer direct sales, independent distributors, and e-commerce platforms.

Finally, tariffs have renewed focus on regulatory compliance and customs classification, as misclassification or inadequate documentation can amplify cost impacts. Stakeholders should expect continued emphasis on supply chain transparency, contractual flexibility, and strategic inventory buffers as standard risk-mitigation tactics in a post-2025 trade environment.

Segment-driven insights that reveal product, application, end-user, and distribution dynamics informing device development, procurement strategies, and clinical adoption

Understanding the market requires a nuanced view of product, application, end-user, and distribution segmentation that together inform product design, go-to-market approaches, and clinical positioning. Based on Product Type, the market is studied across Disposable Manipulator and Reusable Manipulator; the Disposable Manipulator is further studied across Mechanical and Pneumatic Inflatable, while the Reusable Manipulator is further studied across Articulating Arm and Manual Screw, which highlights the divergent engineering priorities between single-use simplicity and durable mechanical complexity. Based on Application, the market is studied across Hysterectomy and Myomectomy; the Hysterectomy is further studied across Laparoscopic, and the Laparoscopic is further studied across Conventional and Robotic Assisted, while the Myomectomy is further studied across Hysteroscopic and Laparoscopic, underscoring how procedural nuance dictates device form factor and control mechanisms.

Based on End User, the market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals; the Ambulatory Surgery Centers is further studied across Freestanding and Hospital Affiliated, the Clinics is further studied across Outpatient and Private, and the Hospitals is further studied across Community and Tertiary, reflecting how setting-specific workflow, sterilization resources, and case-mix shape purchasing decisions. Based on Distribution Channel, the market is studied across Direct, Distributor, and Ecommerce; the Direct is further studied across Manufacturer Sales Representatives and Online, the Distributor is further studied across Medical Distributors and OEM Partners, and the Ecommerce is further studied across Company Websites and Third-Party Portals, illustrating the multiplicity of routes to market and the importance of tailored channel strategies.

Taken together, these segmentation layers reveal that device design choices cannot be decoupled from intended application and end-user operating context. Manufacturers and purchasers must therefore align specifications, training, and support models with the precise clinical and commercial segmentation they intend to serve.

Regional dynamics and cross-border trends across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence manufacturing, regulatory alignment, and market access

Regional dynamics exert a powerful influence on regulatory pathways, manufacturing strategy, and market access approaches, with three macro regions demonstrating distinct patterns. In the Americas, hospitals and ambulatory surgery centers prioritize interoperability with established surgical platforms, infection control standards, and strong post-market surveillance, which encourages manufacturers to emphasize clinical evidence and local servicing capabilities. Trade policy developments and an extensive network of distribution partners also shape procurement timelines and total cost considerations across the region.

In Europe, Middle East & Africa, stakeholders face a diverse regulatory mosaic and varying levels of clinical infrastructure, prompting device suppliers to adopt flexible compliance strategies and modular product offerings. Centralized regulatory frameworks in parts of Europe contrast with localized requirements elsewhere in the region, making regulatory intelligence and targeted clinical engagement critical for market entry and scale-up. Cost containment policies and national procurement mechanisms further influence product positioning and value messaging.

In Asia-Pacific, the combination of rapidly modernizing surgical facilities, strong local manufacturing ecosystems, and varying reimbursement landscapes creates opportunities for both global innovators and regional manufacturers. Adoption of minimally invasive and robotic-assisted techniques is accelerating in many markets, yet differences in sterilization infrastructure and procurement pathways require adaptable distribution models. Across all regions, manufacturers that can align manufacturing footprints, regulatory dossiers, and go-to-market channels with regional realities will reduce friction and accelerate adoption.

Competitive and collaborative company strategies that illuminate innovation pipelines, channel partnerships, manufacturing footprints, and go-to-market differentiation

Company strategies in this sector are being defined by a triad of priorities: product differentiation through engineering and human factors, channel optimization to reach diverse clinical settings, and partnership-driven scale to accelerate innovation. Large medical device manufacturers continue to invest in incremental improvements to durability, ergonomics, and sterilization compatibility, while smaller specialized firms focus on niche innovation such as advanced inflatable systems or low-profile articulating manipulators that meet specific surgeon preferences. Conversely, some companies pursue platform integration with surgical robotics or endoscopic imaging suppliers to offer bundled clinical value.

Strategic partnerships with distributors, hospital system groups, and OEM partners remain a critical route to market expansion, enabling manufacturers to combine clinical training programs with after-sales service and localized inventory management. Mergers and acquisitions are selectively used to acquire complementary technologies or to secure manufacturing capacity in lower-cost regions. Across all company types, investment in clinician training, evidence generation, and post-market surveillance is central to adoption in technical procedures where surgeon confidence and reproducibility are decisive.

Ultimately, companies that articulate clear differentiation, demonstrate clinical benefit through rigorous usability and safety data, and maintain flexible distribution networks will be best positioned to capture opportunities as clinical practices and procurement models evolve.

Actionable recommendations for industry leaders to optimize product roadmaps, supply chains, purchasing policies, and stakeholder engagement for long-term resilience

Industry leaders should pursue a set of actionable moves that balance short-term operational resilience with long-term clinical adoption and commercial growth. First, align product development with procedural workflows by embedding surgeons and sterile processing teams into iterative design and human factors testing, thereby ensuring devices meet real-world operating room constraints and sterilization cycles. Second, diversify sourcing and consider nearshoring critical components while standardizing non-critical parts to reduce tariff and supply disruption risk, complemented by scenario-based inventory planning.

Third, optimize channel strategies by segmenting customers by setting and procurement complexity: direct engagement and clinical training for tertiary hospitals, distributor partnerships for broad geographic coverage, and streamlined e-commerce options for repeatable disposable products. Fourth, proactively engage with regulators and payers to clarify labeling and reimbursement pathways, investing in post-market data collection and traceability to build trust and support purchasing decisions. Fifth, address environmental and lifecycle concerns by evaluating recyclable materials and take-back programs where feasible, and by communicating lifecycle impacts transparently to purchasing stakeholders.

Finally, prioritize clinician education and service models that reduce adoption friction, including simulation-based training, on-site support during the early adoption phase, and clear protocols that integrate devices into standard operating procedures. Executed together, these actions create a pragmatic roadmap for sustainable commercial execution.

Robust research methodology outlining primary and secondary data collection, expert validation, regulatory analysis, and quality assurance protocols used in this study

This study employed a mixed-methods research approach designed to triangulate insights from primary clinical stakeholders, procurement professionals, regulatory documentation, and technical literature. Primary research included structured interviews with practicing gynecologic surgeons, sterile processing leaders, hospital procurement managers, and distribution executives to capture real-world device usage patterns, pain points, and procurement criteria. Expert validation panels reviewed prototype findings to ensure clinical plausibility and to surface nuanced workflow implications that drive product preference.

Secondary research encompassed a comprehensive review of regulatory guidance, product labeling, patent filings, and publicly available clinical procedure literature to map device classifications and safety considerations. Supply chain mapping was used to identify key component origins, distribution routes, and potential tariff exposure, while human factors and usability data were synthesized to evaluate device ergonomics and sterilization demands. Where available, post-market surveillance and adverse event reporting were analyzed to understand safety signals and mitigation strategies.

Data synthesis relied on iterative triangulation: cross-validation of interview themes against documented regulatory requirements and technical specifications. Quality assurance protocols included methodological transparency, interview transcript archiving, and calibration sessions among analysts to minimize bias. Together, these methods produced a robust evidence base for the insights and recommendations presented.

Conclusion synthesizing clinical, operational, regulatory, and commercial insights to guide strategic decisions and near-term implementation priorities

The cumulative analysis highlights that device form factor, clinical application, and operating context jointly determine adoption pathways and commercial potential. Clinical imperatives such as patient safety, procedural efficiency, and surgeon ergonomics continue to drive innovation toward both sophisticated reusable mechanisms and simplified disposable designs, with the choice often determined by the interplay of sterilization capabilities, case mix, and procurement models. In parallel, regulatory scrutiny and trade policy developments have brought supply chain resilience and compliance into sharper focus, making manufacturing flexibility and component sourcing strategic priorities.

Commercial success will favor organizations that couple engineering excellence with deep clinical engagement and flexible distribution models adapted to the requirements of ambulatory surgery centers, clinics, and hospitals. Evidence generation, clinician training, and robust after-sales support will remain indispensable for driving adoption in technically complex procedures. Finally, environmental considerations and lifecycle impacts will increasingly factor into purchasing decisions, prompting manufacturers to proactively address sustainability while balancing clinical and economic trade-offs.

In closing, stakeholders who integrate clinical insight, supply chain foresight, and regulatory intelligence into cohesive strategic plans will be better positioned to navigate the evolving landscape and deliver practical value to surgical teams and health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of disposable uterine manipulators to minimize cross contamination in minimally invasive procedures
  • 5.2. Integration of smart sensor technology into uterine manipulators for enhanced surgical precision and safety
  • 5.3. Expansion of single incision laparoscopic surgery driving demand for low profile uterine manipulation devices
  • 5.4. Rising use of articulating uterine manipulators to improve access and visualization during complex hysterectomy procedures
  • 5.5. Increasing partnerships between medical device companies and research institutes to develop next generation uterine manipulators
  • 5.6. Growing emphasis on cost effective uterine manipulation solutions in emerging markets with expanding gynecological surgery volumes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Uterine Manipulation Devices Market, by Product Type

  • 8.1. Disposable Manipulator
    • 8.1.1. Mechanical
    • 8.1.2. Pneumatic Inflatable
  • 8.2. Reusable Manipulator
    • 8.2.1. Articulating Arm
    • 8.2.2. Manual Screw

9. Uterine Manipulation Devices Market, by Application

  • 9.1. Hysterectomy
    • 9.1.1. Laparoscopic
      • 9.1.1.1. Conventional
      • 9.1.1.2. Robotic Assisted
  • 9.2. Myomectomy
    • 9.2.1. Hysteroscopic
    • 9.2.2. Laparoscopic

10. Uterine Manipulation Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
    • 10.1.1. Freestanding
    • 10.1.2. Hospital Affiliated
  • 10.2. Clinics
    • 10.2.1. Outpatient
    • 10.2.2. Private
  • 10.3. Hospitals
    • 10.3.1. Community
    • 10.3.2. Tertiary

11. Uterine Manipulation Devices Market, by Distribution Channel

  • 11.1. Direct
    • 11.1.1. Manufacturer Sales Representatives
    • 11.1.2. Online
  • 11.2. Distributor
    • 11.2.1. Medical Distributors
    • 11.2.2. OEM Partners
  • 11.3. Ecommerce
    • 11.3.1. Company Websites
    • 11.3.2. Third-Party Portals

12. Uterine Manipulation Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Uterine Manipulation Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Uterine Manipulation Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Ethicon, Inc.
    • 15.3.2. Karl Storz SE & Co. KG
    • 15.3.3. Medtronic plc
    • 15.3.4. B. Braun Melsungen AG
    • 15.3.5. ConMed Corporation
    • 15.3.6. CooperSurgical, Inc.
    • 15.3.7. Richard Wolf GmbH
    • 15.3.8. Stryker Corporation
    • 15.3.9. Smith & Nephew plc
    • 15.3.10. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. UTERINE MANIPULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. UTERINE MANIPULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UTERINE MANIPULATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PNEUMATIC INFLATABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ARTICULATING ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUAL SCREW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTEROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY TERTIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MANUFACTURER SALES REPRESENTATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY OEM PARTNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY THIRD-PARTY PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL UTERINE MANIPULATION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY LAPAROSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY MYOMECTOMY, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DIRECT, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY DISPOSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY REUSABLE MANIPULATOR, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA UTERINE MANIPULATION DEVICES MARKET SIZE, BY HYSTERECTOMY, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA UTERINE MANIPULATION DEV